Revelation Biosciences (REVB) Short Interest Ratio & Short Volume → The Worst is Yet to Come… (From Porter & Company) (Ad) Free REVB Stock Alerts $1.93 +0.28 (+16.97%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Revelation Biosciences Short Interest DataCurrent Short Interest24,800 sharesPrevious Short Interest17,700 sharesChange Vs. Previous Month+40.11%Dollar Volume Sold Short$48,360.00Short Interest Ratio0.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares1,630,000 sharesFloat Size1,630,000 sharesShort Percent of Float1.52%Today's Trading Volume112,291 sharesAverage Trading Volume33,569 sharesToday's Volume Vs. Average335% Short Selling Revelation Biosciences ? Sign up to receive the latest short interest report for Revelation Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartREVB Short Interest Over TimeREVB Days to Cover Over TimeREVB Percentage of Float Shorted Over Time Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. Revelation Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202424,800 shares $48,360.00 +40.1%1.5%0.2 $1.95 4/30/202417,700 shares $37,299.21 -4.3%1.1%0.1 $2.11 4/15/202418,500 shares $33,762.50 -43.6%1.1%0 $1.83 3/31/202432,800 shares $89,872.00 No Change8.3%0.1 $2.74 3/15/202432,800 shares $79,048.00 -31.5%8.3%0.1 $2.41 2/29/202447,900 shares $174,835.00 +32.7%12.3%0.1 $3.65 Get the Latest News and Ratings for REVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202436,100 shares $109,022.00 -70.0%9.2%0.1 $3.02 1/31/2024120,200 shares $1.06 million +526.0%30.8%0.6 $8.80 1/15/2024577,000 shares $8.20 million +27.7%9.3%5.8 $14.22 12/31/2023451,700 shares $226,166.19 +4.7%7.3%6.7 $0.50 12/15/2023431,400 shares $237,701.40 +1,878.9%7.0%7.2 $0.55 11/30/202321,800 shares $15,763.58 -29.5%0.4%0.4 $0.72 11/15/202330,900 shares $19,476.27 +134.1%0.5%0.6 $0.63 10/31/202313,200 shares $7,933.20 -50.6%0.2%0.2 $0.60 10/15/202326,700 shares $18,206.73 +69.0%0.4%0.4 $0.68 9/30/202315,800 shares $10,892.52 +79.6%0.3%0.2 $0.69 9/15/20238,800 shares $6,688.00 +27.5%0.1%0.1 $0.76 8/31/20236,900 shares $4,637.49 -11.5%0.1%0.1 $0.67 8/15/20237,800 shares $5,588.70 +14.7%0.1%0.1 $0.72 7/31/20236,800 shares $5,576.68 -26.9%0.1%0 $0.82 7/15/20239,300 shares $7,786.89 -35.9%0.2%0 $0.84 6/30/202314,500 shares $13,735.85 -74.6%0.3%0 $0.95 6/15/202357,000 shares $63,270.00 -39.8%1.0%0.1 $1.11 5/31/202394,700 shares $99,435.00 +38.5%1.6%0.1 $1.05 5/15/202368,400 shares $77,292.00 -26.8%1.2%0.1 $1.13 4/30/202393,400 shares $100,872.00 -44.9%2.2%0.1 $1.08 3/31/2020100 shares $2,334.00 -90.0%N/A0 $23.34 3/13/20201,000 shares $25,500.00 -9.1%N/A0.2 $25.50 2/28/20201,100 shares $37,609.00 +450.0%N/A0.1 $34.19 2/14/2020200 shares $7,470.00 -71.4%N/A0 $37.35 1/31/2020700 shares $25,305.00 +600.0%N/A0.1 $36.15 1/15/2020100 shares $3,832.00 No ChangeN/A0 $38.32 12/31/2019100 shares $3,940.00 -83.3%N/A0 $39.40 REVB Short Interest - Frequently Asked Questions What is Revelation Biosciences' current short interest? Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 24,800 shares of REVB short. 1.52% of Revelation Biosciences' shares are currently sold short. Learn More on Revelation Biosciences' current short interest. What is a good short interest percentage for Revelation Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.52% of Revelation Biosciences' floating shares are currently sold short. Is Revelation Biosciences' short interest increasing or decreasing? Revelation Biosciences saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 24,800 shares, an increase of 40.1% from the previous total of 17,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Revelation Biosciences' float size? Revelation Biosciences currently has issued a total of 1,630,000 shares. Some of Revelation Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Revelation Biosciences currently has a public float of 1,630,000 shares. How does Revelation Biosciences' short interest compare to its competitors? 1.52% of Revelation Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Revelation Biosciences: TransCode Therapeutics, Inc. (2.66%), Guardion Health Sciences, Inc. (14.30%), Moleculin Biotech, Inc. (1.53%), Eterna Therapeutics Inc. (1.89%), Monopar Therapeutics Inc. (0.89%), ABVC BioPharma, Inc. (6.77%), Vaxxinity, Inc. (3.61%), Oragenics, Inc. (2.07%), Chemomab Therapeutics Ltd. (0.88%), Alterity Therapeutics Limited (0.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Revelation Biosciences stock? Short selling REVB is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. REVB shares are trading up $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Revelation Biosciences? A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of REVB, which in turn drives the price of the stock up even further. How often is Revelation Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVB, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: RNAZ Short Interest GHSI Short Interest MBRX Short Interest ERNA Short Interest MNPR Short Interest ABVC Short Interest VAXX Short Interest OGEN Short Interest CMMB Short Interest ATHE Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REVB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceLEAKED: Jeff Bezos' $330 Million GambleBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.